Your browser doesn't support javascript.
loading
C1q+ macrophages: passengers or drivers of cancer progression.
Revel, Margot; Sautès-Fridman, Catherine; Fridman, Wolf-Herman; Roumenina, Lubka T.
Afiliación
  • Revel M; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.
  • Sautès-Fridman C; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.
  • Fridman WH; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.
  • Roumenina LT; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France. Electronic address: lubka.roumenina@sorbonne-universite.fr.
Trends Cancer ; 8(7): 517-526, 2022 07.
Article en En | MEDLINE | ID: mdl-35288093
The omics era made possible the quest for efficient markers for cancer progression and revealed that macrophage populations are much more complex than just the M1/M2 dichotomy. Complement C1q pops up as a marker of a tolerogenic and immunosuppressive macrophage populations in both healthy and tumor tissues, but the specific role of C1q+ tumor-associated macrophages (TAM) is poorly understood. C1q is co-expressed in healthy and tumor macrophages with human leukocyte antigen DR (HLA-DR), Apolipoprotein E (APOE), and mannose receptor C-type 1 (MRC1) (CD206), suggesting a resident origin of this population. TAM expressing C1q correlate with T cell exhaustion and poor prognosis in numerous cancers. Herein, we discuss the plural roles of C1q in these macrophages and how it could drive cancer progression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complemento C1q / Neoplasias Límite: Humans Idioma: En Revista: Trends Cancer Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complemento C1q / Neoplasias Límite: Humans Idioma: En Revista: Trends Cancer Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos